Mifepristone Helped Control Diabetes in Those With Hypercortisolism

(MedPage Today) — CHICAGO — Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and hypercortisolism, a randomized placebo-controlled trial showed.
Among 136 patients, the least squares mean…